Reflections on Model-Informed Drug Development

被引：0
|
作者：
Lesko, Lawrence J. [1 ]
van der Graaf, Piet H. [2 ,3 ]
机构：
[1] Univ Florida, Coll Pharm, Ctr Pharmacometr & Syst Pharmacol, Lake Nona, FL 32611 USA
[2] Certara, Appl BioSimulat, Canterbury, England
[3] Leiden Acad Ctr Drug Res, Leiden, Netherlands
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 116卷 / 02期
关键词：
D O I：
10.1002/cpt.3335
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：267 / 270
页数：4
相关论文
共 50 条
  • [1] Perspective on model-informed drug development
    Lesko, Lawrence J.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (10): : 1127 - 1129
  • [2] Model-Informed Drug Development for Malaria Therapeutics
    Andrews, Kayla Ann
    Wesche, David
    McCarthy, James
    Mohrle, Jorg J.
    Tarning, Joel
    Phillips, Luann
    Kern, Steven
    Grasela, Thaddeus
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 567 - 582
  • [3] Model-Informed Drug Development (MIDD) for Antimicrobials
    Lin, Yu-Wei
    Cheung, S. Y. Amy
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (06)
  • [4] Model-Informed Drug Development in Pediatric Dose Selection
    Bi, Youwei
    Liu, Jiang
    Li, Fang
    Yu, Jingyu
    Bhattaram, Atul
    Bewernitz, Michael
    Li, Ruo-jing
    Ahn, Jihye
    Earp, Justin
    Ma, Lian
    Zhuang, Luning
    Yang, Yuching
    Zhang, Xinyuan
    Zhu, Hao
    Wang, Yaning
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 : S60 - S69
  • [5] Model-Informed Drug Development: A Regulatory Perspective on Progress
    Zhu, Hao
    Huang, Shiew Mei
    Madabushi, Rajanikanth
    Strauss, David G.
    Wang, Yaning
    Zineh, Issam
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 91 - 93
  • [6] The implications of model-informed drug discovery and development for tuberculosis
    Muliaditan, Morris
    Davies, Geraint R.
    Simonsson, Ulrika S. H.
    Gillespie, Stephen H.
    Della Pasqua, Oscar
    DRUG DISCOVERY TODAY, 2017, 22 (03) : 481 - 486
  • [7] Data standards for model-informed drug development: an ISoP initiative
    Radivojevic, Andrijana
    Corrigan, Brian
    Downie, Nicholas
    Fox, Robert
    Fiedler-Kelly, Jill
    Liu, Huan
    Melhem, Murad
    Radke, David
    Schaefer, Peter
    Su, Jing
    Swat, Maciej J.
    Teuscher, Nathan S.
    Thanneer, Neelima
    Zong, Alice
    Wilkins, Justin J.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 (05) : 659 - 661
  • [8] A Holistic and Integrative Approach for Advancing Model-Informed Drug Development
    Madabushi, Rajanikanth
    Wang, Yaning
    Zineh, Issam
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (01):
  • [9] Model-Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor
    Gupta, Neeraj
    Hanley, Michael J.
    Diderichsen, Paul M.
    Yang, Huyuan
    Ke, Alice
    Teng, Zhaoyang
    Labotka, Richard
    Berg, Deborah
    Patel, Chirag
    Liu, Guohui
    van de Velde, Helgi
    Venkatakrishnan, Karthik
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (02) : 376 - 387
  • [10] Data standards for model-informed drug development: an ISoP initiative
    Andrijana Radivojevic
    Brian Corrigan
    Nicholas Downie
    Robert Fox
    Jill Fiedler-Kelly
    Huan Liu
    Murad Melhem
    David Radke
    Peter Schaefer
    Jing Su
    Maciej J. Swat
    Nathan S. Teuscher
    Neelima Thanneer
    Alice Zong
    Justin J. Wilkins
    Journal of Pharmacokinetics and Pharmacodynamics, 2018, 45 : 659 - 661
12345